I read a study where they completely alleviated MJ Withdrawal with Tylenol and Chocolate... no shit. I tried it yesterday and this morning. And althought it might be a plecebo effect, I feel great. Woth a try.

Here is a little copypasta for you to enjoy with breakfast.
Subject data

Age: 23
Weight: 145lb
Height: 5' 7"
BMI: 22.7
Current supplements/medication: GliSODin (100mg, daily in weekly on/off cycles), Alpha-GPC (250mg, daily), Omega 3-6-9 (600mg, daily), multivitamin (3-4x/week), Melatonin (500µg, 3-4x/week), Phenibut (1-2x/week)*, Zolpidem tartate (5mg, 1-2x/week)*
Additional notes: Subject is well-educated (B.S., M.S., PhD Candidacy), actively monitors a vegetarian diet, in excellent physical condition (average resting heart-rate [HRrest] is 54 BPM) and of relatively healthy mental status (diagnosed major depressive disorder, no incidence of significant clinical depression in 6mo.).

*Phenibut & Zolpidem use were temporarily discontinued 3 weeks prior to trial initiation with no significant withdrawal or side-effects.

Subject Cannabis/Cannabinoid use history: The subject was a regular consumer of Cannabis from age 16-23, ingesting ~500-1,000mg of high-quality (18%+ THC) Cannabis daily from age 19-23 with intermittent 5-6 day cessation periods occurring 1-3x/year. Previous use was regular but not daily (~4-5x/week). Over the past 18 months, the subject has intermittently experimented with synthetic cannabinoid agonists (orally, transdermally and through vaporization [rarely]) not limited to but including CP-47,497/55,940, HU-210, JWH-007/015/018/019/073/081/133/200/210/250, WIN 55,212-2. The subject has not previously noted significant side-effects from regular usage, though suffers withdrawal symptoms upon cessation which include an increase in HRrest and blood-pressure, increased irritability and generalized anxiety, difficulty in initiating and maintaining proper sleep, poor mood and motivation, increased sensitivity to painful stimuli, gastric discomfort with decreased frequency of bowl movements, severely decreased appetite and increased incidence of both conscious and unconscious (sleeping) bruxism.

Study: The subject ceased all Cannabis/Cannabinoid consumption without tapering from the above average doses (500-1,000mg/day, Cannabis). Immediately the subject began supplementing with 3-4oz 78% chocolate spread intermittently throughout the day, 50mg Safflower-oil NAPE 1x/day in the morning, along with additional 5mg pantothenic acid, 1200mg Omega 3-6-9 complex. The subject also began using a mild glycerol extract in place of sucrose in his morning coffee. With each meal, the subject ingests 500mg paracematol. In addition to the subject's regular exercise regimen (90min cardiovascular oriented cycling 3x/week, 60min strength training 2x/week), a 60min cardiovascular exercise (running) was incorporated into the subject's routine on the 2 previously-designated "off-days."

After 10 days, the subject reported absolutely no withdrawal symptoms. Appetite was maintained at standard levels, no anxiety/irritability was reported, sleep patterns noted as regular (100-110min REM/night, as monitored by EEG), no incidence of bruxism, sensitivity to painful stimuli, or change in frequency of bowel movements. A mild increase in HRrest (∆+5-7BPM for days 1-6 post-cessation, +/-0BPM thereafter) was noted with no change in mean blood-pressure.

On day 10, the subject ceased consumption of NAPE-isolate and reduced paracematol to 1x/day with no notable change in effect. On day 15 the subject ceased consumption of additional Omega 3-6-9 complex, glycerol, paracematol and pantothenic acid supplementation with no notable change in effect. On day 17 the subject resumed normal exercise routine by returning to two "off-days" with no notable effect. The study ended on day 30 with the subject reporting normal behavior, no notable side-effects from withdrawal, no notable cravings to re-administer Cannabis/Cannabinoids even when probed with multiple cues (the presence of smoke, the aroma of fresh Cannabis, and the tactile handling of glassware used for Cannabis consumption). A follow-up study on day 60 reports no change. Compliance with cessation was monitored by self-report.

Conclusions: The above study suggests that a chemical and physical supplementation diet may act to prevent the development of Cannabis/Cannabinoid-mediated withdrawal symptoms in some subjects. Further study is required to generalize to a larger population. The individual contributions of each element are debatable, and future studies with isolated or combined supplementation are required to further define the effects of the regimen on abolishing Cannabis/Cannabinoid-mediated withdrawal.